IX
Incannex Healthcare Limited
IXHL · NASDAQ
$3.59 -1.10% (-$0.04)
1M +10.47%
Market Cap $43.0M
P/E Ratio -
Div. Yield -
ROE 115.06%
Bulios Fair Price
$2.14
40.4% downside
Trenutna cena
$3.59
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica IXHL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
32 /100
Expensive P/S 499.45x
P/B 3.21x
P/E N/A
Growth
0 /100
Declining Rev. growth 52.15%
Book val. growth 28.08%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 186.05%
Net margin 54,517.40%
FCF margin 14,559.30%
Quality
0 /100
Poor ROIC 168.02%
ROE 115.06%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.02x
Current ratio 2.86x
Int. coverage -78.51x
Stability
1 /100
Unstable Beta 2.83x
EPS volatility 616.48%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IXHL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joel Bradley Latham
Employees
12
Headquarters
Sydney
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report